1887

Abstract

Summary

Isolates of species from 18 patients with keratomycosis were examined for their C-29 and C-31 sterol content and for their capacity to synthesise mycotoxins. All isolates were resistant to azole antifungal agents and the sterol contents were indistinguishable. In-vitro toxin production was monitored by gas chromatography–mass spectrometry; 13 isolates produced nivalenol, six produced deoxynivalenol, nine gave T-2 toxin and two showed the presence of diacetoxyscirpenol at different time intervals. However, neither sterol content nor toxin production appeared to be related to the severity of infections observed in patients.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-41-3-204
1994-09-01
2024-11-06
Loading full text...

Full text loading...

/deliver/fulltext/jmm/41/3/medmicro-41-3-204.html?itemId=/content/journal/jmm/10.1099/00222615-41-3-204&mimeType=html&fmt=ahah

References

  1. Thomas PA, Geraldine P. Fungal keratitis due to Fusarium and other fungi. J Mycol Méd 1992; 2:121–131
    [Google Scholar]
  2. Rajasekaran J, Thomas PA, Srinivasan R. Ketoconazole in keratomycosis. Blodi F, Brancato R, Cristini G. et al.Proceedings of the XXVth International Congress of Ophthalmology 19862462–2467
    [Google Scholar]
  3. Chaiprasert A. Rare and unusual fungal diseases. Jacobs PH, Nall L. Antifungal drug therapy: a complete guide for the practitioner New York: Marcel Dekker Inc.; 1990279–296
    [Google Scholar]
  4. Cuero RG. Ecological distribution of Fusarium solani and its opportunistic action related to mycotic keratitis in Cali, Colombia. J Clin Microbiol 1980; 12:455–461
    [Google Scholar]
  5. Booth C. The genus Fusarium Buckinghamshire, England: Commonwealth Agricultural Bureau; 1985
    [Google Scholar]
  6. Bhat RV, Ramakrishna Y, Beedu SR, Munshi KL. Outbreak of tricothecene mycotoxicosis associated with consumption of mould-damaged wheat products in Kashmir Valley, India. Lancet 1989; 1:35–37
    [Google Scholar]
  7. Krogh P, Christensen DH, Hald B. et al. Natural occurrence of the mycotoxin fusarochromanone, a metabolite of Fusarium equiseti, in cereal feed associated with tibial dyschondroplasia. Appl Environ Microbiol 1989; 55:3184–3188
    [Google Scholar]
  8. Yoshizawa T, Mirocha CJ, Behrens JC, Swanson SP. Metabolic fate of T-2 toxin in a lactating cow. Food Cosmet Toxicol 1981; 19:31–39
    [Google Scholar]
  9. Weitzman I. Saprophytic molds as agents of cutaneous and subcutaneous infection in the immunocompromised host. Arch Dermatol 1986; 122:1161–1168
    [Google Scholar]
  10. Wheeler MS, McGinnis MR, Schell WA, Walker DH. Fusarium infection in burned patients. Am J Clin Pathol 1981; 75:304–311
    [Google Scholar]
  11. Anaissie E, Kantarjian H, Ro J. et al. The emerging role of Fusarium infections in patients with cancer. Medicine 1988; 67:77–83
    [Google Scholar]
  12. Thomas PA, Abraham DJ, Kalavathy CM, Rajasekaran J. Oral itraconazole therapy for mycotic keratitis. Mycoses 1988; 31:271–279
    [Google Scholar]
  13. Shadomy S, Espinel-Ingroff A, Cartwright RY. Laboratory studies with antifungal agents: susceptibility tests and bioassays. Lennette EH, Balows A, Hausler WJ, Shadomy HJ. Manual of clinical microbiology, 4th edn. Washington DC: American Society of Microbiology; 1985991–999
    [Google Scholar]
  14. Howell SA, Moore MK, Mallet AI, Noble WC. Sterols of fungi responsible for superficial skin and nail infection. J Gen Microbiol 1990; 136:241–247
    [Google Scholar]
  15. Raza SK, Howell SA, Mallet . Identification of mycotoxins in keratomycosis-derived Fusarium isolates by gas chromatography-mass spectrometry. J Chromatogr Biomed Appl 1993; 620:243–249
    [Google Scholar]
  16. Warnock DW. Methods with antifungal drugs. Evans EGV, Richardson MD. Medical mycology: a practical approach Oxford: IRL Oxford University Press; 1989235–259
    [Google Scholar]
  17. vanden Bossche H, Marichal P, Odds FC, Le Jeune L, Coene MC. Characterisation of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 1992; 36:2602–2610
    [Google Scholar]
  18. Howell SA, Mallet AI, Noble WC. A comparison of the sterol content of multiple isolates of the Candida albicans Darlington strain with other clinically azole-sensitive and -resistant strains. J Appl Bacteriol 1990; 69:692–696
    [Google Scholar]
  19. Abbas HK, Mirocha CJ, Shier WT. Mycotoxins produced from fungi isolated from foodstuffs and soil: comparison of toxicity in fibroblasts and rat feeding tests. Appl Environ Microbiol 1984; 48:654–661
    [Google Scholar]
  20. Bosch U, Mirocha CJ, Abbas HK, di Menna M. Toxicity and toxin production by Fusarium isolates from New Zealand. Mycopathologia 1989; 108:73–79
    [Google Scholar]
  21. Mirocha CJ, Pathre SV, Schauerhamer B, Christensen CM. Natural occurrence of Fusarium toxins in feedstuff. Appl Environ Microbiol 1976; 32:553–556
    [Google Scholar]
  22. Bhavanishankar TN, Ramesh HP, Shantha T. Dermal toxicity of Fusarium toxins in combinations. Arch Toxicol 1988; 61:241–244
    [Google Scholar]
  23. Frisvad JC, Filtenborg O. Classification of Terverticilliate Penicillia based on profiles of mycotoxins and other secondary metabolites. Appl Environ Microbiol 1983; 46:1301–1310
    [Google Scholar]
  24. Thrane U. Detection of toxigenic Fusarium isolates by thin layer chromatography. Lett Appl Microbiol 1986; 3:93–96
    [Google Scholar]
  25. Drysdale RB, Bratt PM. Electrophoretic patterns of enzymes from isolates of Fusarium graminearum. Trans Br Mycol Soc 1971; 57:172–175
    [Google Scholar]
/content/journal/jmm/10.1099/00222615-41-3-204
Loading
/content/journal/jmm/10.1099/00222615-41-3-204
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error